Xiaobo Man

16 papers receiving 365 citations

Peers

Xiaobo Man
Comparison fields: 5 of 61
  • Hepatology 49
  • Cancer Research 62
  • Cell Biology 66
  • Molecular Biology 237
  • Oncology 92
Replace Raquel Bermudo with:
Raquel Bermudo Spain
François Béliveau Canada
Patrick Reichl Austria
Jiamin Cheng China
H Naundorf Germany
Katherine T. Ostapoff United States
Annalisa Chiriatti Italy
Rui‐xia Sun China
Agnes Csiszar Austria
Jinwei Hao Australia
Xiaobo Man relative to Raquel Bermudo Spain Raquel Bermudo's profile →
Citations per field
00.5×3.3×
Raquel Bermudo · 1×
Citations per year

Countries citing papers authored by Xiaobo Man

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Man more than expected).

Fields of papers citing papers by Xiaobo Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Man. The network helps show where Xiaobo Man may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaobo Man, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaobo Man Line = papers co-authored together Xiaobo Man links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 200590
2 200651
3 200547
4 200941
5 200931
6 201225
7 201523
8 200922
9 200418
10
[Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma].
200712
11 20052
12 20061
13 20041
14 20121
15 20131
16
Gradual upregulation of OCI-5 expression during occurrence and progression of rat hepatocellular carcinoma.
20061

About Xiaobo Man

Xiaobo Man is a scholar working on Hepatology, Biotechnology, Cancer Research, Immunology and Molecular Biology, having authored 16 papers that have together received 367 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Protein Tyrosine Phosphatases (2 papers), Galectins and Cancer Biology (2 papers), Cancer Research and Treatments (2 papers), Glycosylation and Glycoproteins Research (2 papers), RNA modifications and cancer (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hepatology (49 citations), Cancer Research (62 citations), Cell Biology (66 citations), Molecular Biology (237 citations) and Oncology (92 citations). Xiaobo Man has collaborated with scholars based in China, Germany and Canada. Frequent co-authors include Baohua Zhang, Hongyang Wang, Liang Tang, Mengchao Wu, Hong‐Yang Wang, Mengchao Wu, Jiarui Wu, Su‐Jun Li, Yexiong Tan and Hong Yi. Their work appears in journals such as Liver International, Clinical Cancer Research, The International Journal of Biochemistry & Cell Biology, Journal of Biological Chemistry and Journal of Surgical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026